Back to results
US 2023/0414503 A1Published application
Topiramate oral liquid suspension and use thereof
AssigneeOWP Pharmaceuticals, Inc.
InventorsPaul Sudhakar, Scott Boyer
Life of this patent
Estimating the term…
Abstract
Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
Claims27
An oral liquid suspension comprising:
- 2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate (topiramate);
- water;
- glycerin;
- propylene glycol,
- polyethylene glycol;
- methylparaben;
- sodium benzoate;
- sorbitol;
- saccharin;
- sucralose;
- xanthan gum;
- carboxymethyl cellulose (CMC);
- sodium phosphate;
- and
- PROSOLV® SMCC 50M (microcrystalline cellulose and colloidal silicon dioxide).
12 more elements
Dependencies are inferred from the claim text.